{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T03:05:49Z","timestamp":1782529549746,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"PM-USHA,  Ministry of Education , Government of India","award":["239\/2025\/HEDN"],"award-info":[{"award-number":["239\/2025\/HEDN"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-025-11321-4","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T07:59:08Z","timestamp":1755244748000},"page":"3615-3634","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Druggability assessments of small peptides as protein\u2013protein interaction inhibitors targeting EED-EZH2 binding within the Polycomb Repressive Complex 2 (PRC2), an epigenetic regulator"],"prefix":"10.1007","volume":"30","author":[{"given":"Varun Thachan","family":"Kundil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharanya C.","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreeja","family":"Chellappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupama","family":"Kizhakkepurayil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soorej Muhammad","family":"Basheer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun Kumar","family":"Gangadharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,15]]},"reference":[{"key":"11321_CR1","doi-asserted-by":"publisher","first-page":"6959","DOI":"10.1073\/pnas.0708078105","volume":"105","author":"MPH Stumpf","year":"2008","unstructured":"Stumpf MPH, Thorne T, de Silva E et al (2008) Estimating the size of the human interactome. Proc Natl Acad Sci USA 105:6959\u20136964. https:\/\/doi.org\/10.1073\/pnas.0708078105","journal-title":"Proc Natl Acad Sci USA"},{"key":"11321_CR2","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1080\/17460441.2018.1430763","volume":"13","author":"M Rosell","year":"2018","unstructured":"Rosell M, Fern\u00e1ndez-Recio J (2018) Hot-spot analysis for drug discovery targeting protein-protein interactions. Expert Opin Drug Discov 13:327\u2013338. https:\/\/doi.org\/10.1080\/17460441.2018.1430763","journal-title":"Expert Opin Drug Discov"},{"key":"11321_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2147\/AABC.S235542","volume":"13","author":"W-H Shin","year":"2020","unstructured":"Shin W-H, Kumazawa K, Imai K et al (2020) Current challenges and opportunities in designing protein-protein interaction targeted drugs. Adv Appl Bioinform Chem 13:11\u201325. https:\/\/doi.org\/10.2147\/AABC.S235542","journal-title":"Adv Appl Bioinform Chem"},{"key":"11321_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031550","volume":"23","author":"J Ol\u00e1h","year":"2022","unstructured":"Ol\u00e1h J, Sz\u00e9n\u00e1si T, Lehotzky A et al (2022) Challenges in discovering drugs that target the protein-protein interactions of disordered proteins. Int J Mol Sci 23:1550. https:\/\/doi.org\/10.3390\/ijms23031550","journal-title":"Int J Mol Sci"},{"key":"11321_CR5","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1101\/gad.1035902","volume":"16","author":"A Kuzmichev","year":"2002","unstructured":"Kuzmichev A, Nishioka K, Erdjument-Bromage H et al (2002) Histone methyltransferase activity associated with a human multiprotein complex containing the enhancer of zeste protein. Genes Dev 16:2893\u20132905. https:\/\/doi.org\/10.1101\/gad.1035902","journal-title":"Genes Dev"},{"key":"11321_CR6","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.tcb.2010.08.011","volume":"20","author":"MT Pedersen","year":"2010","unstructured":"Pedersen MT, Helin K (2010) Histone demethylases in development and disease. Trends Cell Biol 20:662\u2013671. https:\/\/doi.org\/10.1016\/j.tcb.2010.08.011","journal-title":"Trends Cell Biol"},{"key":"11321_CR7","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1161\/CIRCRESAHA.111.252205","volume":"110","author":"A He","year":"2012","unstructured":"He A, Ma Q, Cao J et al (2012) Polycomb repressive complex 2 regulates normal development of the mouse heart. Circ Res 110:406\u2013415. https:\/\/doi.org\/10.1161\/CIRCRESAHA.111.252205","journal-title":"Circ Res"},{"key":"11321_CR8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nature09784","volume":"469","author":"R Margueron","year":"2011","unstructured":"Margueron R, Reinberg D (2011) The polycomb complex PRC2 and its mark in life. Nature 469:343\u2013349. https:\/\/doi.org\/10.1038\/nature09784","journal-title":"Nature"},{"key":"11321_CR9","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nature08398","volume":"461","author":"R Margueron","year":"2009","unstructured":"Margueron R, Justin N, Ohno K et al (2009) Role of the polycomb protein EED in the propagation of repressive histone marks. Nature 461:762\u2013767. https:\/\/doi.org\/10.1038\/nature08398","journal-title":"Nature"},{"key":"11321_CR10","doi-asserted-by":"publisher","first-page":"5634","DOI":"10.1128\/MCB.18.10.5634","volume":"18","author":"O Denisenko","year":"1998","unstructured":"Denisenko O, Shnyreva M, Suzuki H, Bomsztyk K (1998) Point mutations in the WD40 domain of Eed block its interaction with Ezh2. Mol Cell Biol 18:5634\u20135642","journal-title":"Mol Cell Biol"},{"key":"11321_CR11","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1128\/MCB.18.5.2825","volume":"18","author":"CA Jones","year":"1998","unstructured":"Jones CA, Ng J, Peterson AJ et al (1998) The Drosophila esc and E(z) proteins are direct partners in polycomb group-mediated repression. Mol Cell Biol 18:2825\u20132834","journal-title":"Mol Cell Biol"},{"key":"11321_CR12","doi-asserted-by":"publisher","first-page":"3586","DOI":"10.1128\/MCB.18.6.3586","volume":"18","author":"RG Sewalt","year":"1998","unstructured":"Sewalt RG, van der Vlag J, Gunster MJ et al (1998) Characterization of interactions between the mammalian polycomb-group proteins Enx1\/EZH2 and EED suggests the existence of different mammalian polycomb-group protein complexes. Mol Cell Biol 18:3586\u20133595. https:\/\/doi.org\/10.1128\/MCB.18.6.3586","journal-title":"Mol Cell Biol"},{"key":"11321_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.mrfmmm.2008.07.010","volume":"647","author":"JA Simon","year":"2008","unstructured":"Simon JA, Lange CA (2008) Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutat Res 647:21\u201329. https:\/\/doi.org\/10.1016\/j.mrfmmm.2008.07.010","journal-title":"Mutat Res"},{"key":"11321_CR14","doi-asserted-by":"publisher","first-page":"158","DOI":"10.6004\/jadpro.2022.13.2.7","volume":"13","author":"R Straining","year":"2022","unstructured":"Straining R, Eighmy W (2022) Tazemetostat: EZH2 inhibitor. J Adv Pract Oncol 13:158\u2013163. https:\/\/doi.org\/10.6004\/jadpro.2022.13.2.7","journal-title":"J Adv Pract Oncol"},{"key":"11321_CR15","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1182\/blood-2021-147904","volume":"138","author":"V Ribrag","year":"2021","unstructured":"Ribrag V, Michot J-M, Igleias L et al (2021) Phase I\/II study of MAK683 in patients with advanced malignancies, including diffuse large B-cell lymphoma. Blood 138:1422. https:\/\/doi.org\/10.1182\/blood-2021-147904","journal-title":"Blood"},{"key":"11321_CR16","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.str.2007.08.007","volume":"15","author":"Z Han","year":"2007","unstructured":"Han Z, Xing X, Hu M et al (2007) Structural basis of EZH2 recognition by EED. Structure 15:1306\u20131315. https:\/\/doi.org\/10.1016\/j.str.2007.08.007","journal-title":"Structure"},{"key":"11321_CR17","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1021\/ci7000346","volume":"47","author":"Z Zhou","year":"2007","unstructured":"Zhou Z, Felts AK, Friesner RA, Levy RM (2007) Comparative performance of several flexible docking programs and scoring functions: enrichment studies for a diverse set of pharmaceutically relevant targets. J Chem Inf Model 47:1599\u20131608. https:\/\/doi.org\/10.1021\/ci7000346","journal-title":"J Chem Inf Model"},{"key":"11321_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.dib.2019.104607","volume":"27","author":"VD Prasasty","year":"2019","unstructured":"Prasasty VD, Istyastono EP (2019) Data of small peptides in SMILES and three-dimensional formats for virtual screening campaigns. Data Brief 27:104607. https:\/\/doi.org\/10.1016\/j.dib.2019.104607","journal-title":"Data Brief"},{"key":"11321_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle NM, Banck M, James CA et al (2011) Open babel: an open chemical toolbox. J Cheminform 3:33. https:\/\/doi.org\/10.1186\/1758-2946-3-33","journal-title":"J Cheminform"},{"key":"11321_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ph15050646","volume":"15","author":"D Giordano","year":"2022","unstructured":"Giordano D, Biancaniello C, Argenio MA, Facchiano A (2022) Drug design by pharmacophore and virtual screening approach. Pharmaceuticals 15:646. https:\/\/doi.org\/10.3390\/ph15050646","journal-title":"Pharmaceuticals"},{"key":"11321_CR21","volume-title":"Drugs from Nature: Targets, Assay Systems and Leads","author":"AK Gangadharan","year":"2024","unstructured":"Gangadharan AK, Kundil VT, Jayanandan A (2024) Computational Tools in Drug-Lead Identification and Development. In: Haridas M, Abdulhameed S, Francis D, Kumar SS (eds) Drugs from Nature: Targets, Assay Systems and Leads. Springer Nature, Singapore"},{"key":"11321_CR22","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ymeth.2014.10.013","volume":"71","author":"A Vuorinen","year":"2015","unstructured":"Vuorinen A, Schuster D (2015) Methods for generating and applying pharmacophore models as virtual screening filters and for bioactivity profiling. Methods 71:113\u2013134. https:\/\/doi.org\/10.1016\/j.ymeth.2014.10.013","journal-title":"Methods"},{"key":"11321_CR23","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10822-006-9087-6","volume":"20","author":"SL Dixon","year":"2006","unstructured":"Dixon SL, Smondyrev AM, Knoll EH et al (2006) PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. methodology and preliminary results. J Comput Aided Mol Des 20:647\u2013671. https:\/\/doi.org\/10.1007\/s10822-006-9087-6","journal-title":"J Comput Aided Mol Des"},{"key":"11321_CR24","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1021\/jm030644s","volume":"47","author":"TA Halgren","year":"2004","unstructured":"Halgren TA, Murphy RB, Friesner RA et al (2004) Glide: a new approach for rapid, accurate docking and scoring. 2. enrichment factors in database screening. J Med Chem 47:1750\u20131759. https:\/\/doi.org\/10.1021\/jm030644s","journal-title":"J Med Chem"},{"key":"11321_CR25","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner RA, Murphy RB, Repasky MP et al (2006) Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein\u2212ligand complexes. J Med Chem 49:6177\u20136196. https:\/\/doi.org\/10.1021\/jm051256o","journal-title":"J Med Chem"},{"key":"11321_CR26","doi-asserted-by":"publisher","first-page":"11225","DOI":"10.1021\/ja9621760","volume":"118","author":"WL Jorgensen","year":"1996","unstructured":"Jorgensen WL, Maxwell DS, Tirado-Rives J (1996) Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. J Am Chem Soc 118:11225\u201311236. https:\/\/doi.org\/10.1021\/ja9621760","journal-title":"J Am Chem Soc"},{"key":"11321_CR27","unstructured":"Kurzweil R (2006) Keynote Speech: Raymond Kurzweil. In: Proceedings of the 2006 ACM\/IEEE conference on Supercomputing. Association for Computing Machinery, New York, NY, USA"},{"key":"11321_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2022.991369","author":"U Dasmahapatra","year":"2022","unstructured":"Dasmahapatra U, Kumar CK, Das S et al (2022) In-silico molecular modelling, MM\/GBSA binding free energy and molecular dynamics simulation study of novel pyrido fused imidazo[4,5-c]quinolines as potential anti-tumor agents. Front Chem. https:\/\/doi.org\/10.3389\/fchem.2022.991369","journal-title":"Front Chem"},{"key":"11321_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbac174","volume":"23","author":"N Sharma","year":"2022","unstructured":"Sharma N, Naorem LD, Jain S, Raghava GPS (2022) ToxinPred2: an improved method for predicting toxicity of proteins. Brief Bioinform 23:bbac174. https:\/\/doi.org\/10.1093\/bib\/bbac174","journal-title":"Brief Bioinform"},{"key":"11321_CR30","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/978-1-4939-2285-7_7","volume-title":"Computational Peptidology","author":"S Gupta","year":"2015","unstructured":"Gupta S, Kapoor P, Chaudhary K et al (2015) Peptide Toxicity Prediction. In: Zhou P, Huang J (eds) Computational Peptidology. Springer, New York, NY, pp 143\u2013157"},{"key":"11321_CR31","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1021\/acs.jcim.9b00225","volume":"59","author":"AL Lomize","year":"2019","unstructured":"Lomize AL, Hage JM, Schnitzer K et al (2019) PerMM: a web tool and database for analysis of passive membrane permeability and translocation pathways of bioactive molecules. J Chem Inf Model 59:3094\u20133099. https:\/\/doi.org\/10.1021\/acs.jcim.9b00225","journal-title":"J Chem Inf Model"},{"key":"11321_CR32","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1182\/blood-2017-08-804344","volume":"131","author":"M Bisserier","year":"2018","unstructured":"Bisserier M, Wajapeyee N (2018) Mechanisms of resistance to EZH2 inhibitors in diffuse large B-cell lymphomas. Blood 131:2125\u20132137. https:\/\/doi.org\/10.1182\/blood-2017-08-804344","journal-title":"Blood"},{"key":"11321_CR33","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1039\/d1md00274k","volume":"13","author":"K-L Liu","year":"2021","unstructured":"Liu K-L, Zhu K, Zhang H (2021) An overview of the development of EED inhibitors to disable the PRC2 function. RSC Med Chem 13:39\u201353. https:\/\/doi.org\/10.1039\/d1md00274k","journal-title":"RSC Med Chem"},{"key":"11321_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.115122","volume":"216","author":"V Ribrag","year":"2025","unstructured":"Ribrag V, Iglesias L, De Braud F et al (2025) A first-in-human phase 1\/2 dose-escalation study of MAK683 (EED inhibitor) in patients with advanced malignancies. Eur J Cancer 216:115122. https:\/\/doi.org\/10.1016\/j.ejca.2024.115122","journal-title":"Eur J Cancer"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11321-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-025-11321-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11321-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T11:33:21Z","timestamp":1779536001000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-025-11321-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,15]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["11321"],"URL":"https:\/\/doi.org\/10.1007\/s11030-025-11321-4","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,15]]},"assertion":[{"value":"20 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}